News

Join Mast at the IBMS 2023, the UK’s largest Biomedical scientist exhibition featuring leading diagnostic companies at ICC Birmingham on 26^th – 28^th September in Hall 4 - Stand 931.

MASTDISCS^® ID Nitrocefin discs enables rapid detection of ß-lactamase enzymes. The presence of ß lactamase confers resistance to penicillin and cephalosporin’s, resulting in inactivation of these antibiotics.

MAST URI^® Plates are made to the current EUCAST breakpoints for urinary tract infections.

Will you 'go blue' for World Antimicrobial Awareness Week this week?

This is the topic Mast Group Product Specialist Emily George will be discussing at the ACB UKMedLab22 scientific meeting on Wednesday 9th November.

MAST^® SPUTAGEST liquefying agent permits easy and effective isolation of organisms from sputum samples.

Reliable and accurate susceptibility testing of mastitis pathogens to Kanamycin-Cefalexin 30-15µg combination is now easier for Veterinary practitioners.

Mast is pleased to announce the launch of Ceftobiprole 5µg to the MASTDISCS^® Antimicrobial Susceptibility Test range.

The prevalence of antibiotic resistance amongst anaerobes is emerging and in recent decades several species have developed resistance to broad spectrum antibiotics such as Meropenem, Piperacillin-Tazobactam and Metronidazole.